Skip to main content
. 2022 Feb 10;64(3):188–195. doi: 10.11622/smedj.2022019

Figure 1.

Figure 1

Flowchart shows the patient selection process in (a) the primary cohort and (b) the validation cohort. *Follow-up patients with serial serum copper and/or serum caeruloplasmin values exceeding reference change value (RCV). WD: Wilson disease